Vol.

No.

November 20, 2015Nov 20, 2015

Free

DOWNLOAD THE PDF

Congressional Panel Chair Questions Whether J&J, Brigham Reported Morcellation Adverse Events to FDA

Cover Story

Free

Congressional Panel Chair Questions Whether J&J, Brigham Reported Morcellation Adverse Events to FDA

By Matthew Bin Han Ong

The House Committee on Energy & Commerce has stepped into a key role in the controversy over power morcellation.

Free

FDA: Federal Law Requires Reporting of Morcellation Adverse Events, But None Were Brought to Agency's Attention For 8 Years

Free

J&J Says There Were No Reportable Morcellation Events; Whistleblower Disagrees—and Produces Letters

By Matthew Bin Han Ong

Capitol Hill

FDA Lists Potentially Avoidable Harms in 20 LDT Case Studies, Including Tests from Duke, Caris and Genomic Health

By Conor Hale

CBER's All-Day Voyage into Slippery Science Ends in 18-6 Vote against Bladder Drug

By Paul Goldberg

NCI Announces Winners of its Outstanding Investigator Awards

In Brief

Kantoff Named Chair of MSKCC Department of Medicine

Michael Lang named CPRIT chief product development officer

Alexandra Levine receives award from Los Angeles County Medical Association

Steven Rosen receives Lifetime Achievement Award from the Israel Cancer Research Fund

International Cancer Genome Consortium publishes 1,200 whole cancer genome sequences online

ASCO publishes 11 principles for CMS payment systems

MD Anderson and Codiack BioSciences form research agreement

Pan-Mass Challenge donates $45 million to Dana-Farber

AARP publishes report on drug retail prices and median household income

Drugs & Targets

Approvals Granted to Darzalex and Ninlaro in Multiple Myeloma

Ninlaro first protesome inhibitor approved in multiple myeloma

Eli Lilly and Merck extend phase III Alimta-Keytruda study collaboration

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 08 - February 27, 2026

Congressional Panel Chair Questions Whether J&J, Brigham Reported Morcellation Adverse Events to FDA

FDA: Federal Law Requires Reporting of Morcellation Adverse Events, But None Were Brought to Agency's Attention For 8 Years

J&J Says There Were No Reportable Morcellation Events; Whistleblower Disagrees—and Produces Letters

FDA Lists Potentially Avoidable Harms in 20 LDT Case Studies, Including Tests from Duke, Caris and Genomic Health

CBER's All-Day Voyage into Slippery Science Ends in 18-6 Vote against Bladder Drug

NCI Announces Winners of its Outstanding Investigator Awards

In Brief

Kantoff Named Chair of MSKCC Department of Medicine

Michael Lang named CPRIT chief product development officer

Alexandra Levine receives award from Los Angeles County Medical Association

Steven Rosen receives Lifetime Achievement Award from the Israel Cancer Research Fund

International Cancer Genome Consortium publishes 1,200 whole cancer genome sequences online

ASCO publishes 11 principles for CMS payment systems

MD Anderson and Codiack BioSciences form research agreement

Pan-Mass Challenge donates $45 million to Dana-Farber

AARP publishes report on drug retail prices and median household income

Drugs & Targets

Approvals Granted to Darzalex and Ninlaro in Multiple Myeloma

Ninlaro first protesome inhibitor approved in multiple myeloma

Eli Lilly and Merck extend phase III Alimta-Keytruda study collaboration

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login